pertuzumab/trastuzumab

pertuzumab and trastuzumab

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for pertuzumab/trastuzumab, covering 2018-09-28 to 2018-09-28. Get the full timeline:

Most recent: Clinical Trial Update: NEOADjuvant Aromatase Inhibitor and Pertuzumab/Trastuzumab for Women With Breast Cancer [Phase 2]